Thoracic Malignancies Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thoracic Malignancies Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thoracic Malignancies Program Today - Breaking & Trending Today

Dostarlimab Plus Chemo Continues to Demonstrate Strong Clinical Efficacy in Advanced NSCLC

Published: October 20, 2023

Dostarlimab plus chemotherapy elicited a higher objective response rate and showcased a numerical improvement in overall survival compared with pembrolizumab and chemotherapy in patients with treatment-naïve, nonsquamous non–small cell lung cancer.

Source: onclive.com

Related Topics:

Comunidad Autonoma De CatalunaEli LillyRoche GenentechDaiichi SankyoNoemi ReguartPharma MarSolange PetersMerck SeronoFoundation MedicineBoehringer IngelheimBristol Myers SquibbDepartment Of OncologyUniversity Hospital Of LausanneEuropean Lung Cancer CongressThoracic Malignancies ProgramUniversity HospitalHospital ClinicBlueprint MedicinesMerck SharpPhosplatin TherapeuticsSeattle GeneticsLung Cancer CongressDostarlimab Plus ChemotherapyPatients With Treatment NaïveNonsquamous Non Small Cell Lung Cancer